1. |
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012, 379(9818): 815-822.
|
2. |
何长民, 张训. 肾脏替代治疗. 上海: 上海科技教育出版社, 2005: 114-115.
|
3. |
Choi HS, Park SY, Kim YM, et al. Medical treatment of severe osteoporosis including new concept of advanced severe osteoporosis. Osteoporos Sarcopenia, 2016, 2(1): 13-19.
|
4. |
Avramovski P, Sikole A. The progression of bone mineral density loss in dialysis patients compared with the general population. Korean J Intern Med, 2012, 27(4): 436-442.
|
5. |
Barreto FC, Barreto DV, Moyses RM, et al. Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. Kidney Int, 2006, 69(10): 1852-1857.
|
6. |
蔡舒婷, 孙雯, 刘红. 骨折风险评估工具(FRAX®)在评价绝经后女性骨密度的临床意义. 中国骨质疏松杂志, 2017, 23(2): 177-182.
|
7. |
景彩霞, 李二乐, 薛亚平. OSTA 指数与体重指数对于绝经后妇女骨质疏松的预测效果评价. 中国骨质疏松杂志, 2015, 21(2): 1083-1086.
|
8. |
张寒, 甘华. 慢性肾脏病患者血管钙化与骨质疏松共同发生机制的研究进展. 医学综述, 2012, 18(18): 2991-2994.
|
9. |
Zhang ZM, Qu YN, Sheng ZF, et al. How to decide in tervention thresholds based on FRAX in central south Chinese postmenopausal women. Endocrine, 2014, 45: 195-197.
|
10. |
Su FM, Liu DH, Chen JF, et al. Development and validation of an Osteoporosis Self-Assessment Tool for Taiwan (OSTAi) postmenopausal women: a sub-study of the Taiwan OsteoPorosis Survey (TOPS). PLoS One, 2015, 10(6): e0130716.
|
11. |
解冰, 田竞, 周大鹏, 等. 辽宁地区绝经后妇女骨质疏松症知识问卷调查分析. 中国骨质疏松杂志, 2014, 20(1): 73-77.
|
12. |
Chen SJ, Chen YJ, Cheng CH, et al. Comparisons of different screening tools for identifying fracture/osteoporosis risk among community-dwelling older people. Medicine (Baltimore), 2016, 95(20): e3415.
|
13. |
Collins AJ, Foley RN, Gilbertson DT. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol, 2009, 4(Suppl 1): S5-S11.
|
14. |
贾凤玉, 孟建中. 血液透析治疗模式和观念的研究进展. 中华临床医师杂志(电子版), 2013, 7(22): 174-176.
|
15. |
丁婷婷, 王会玲, 陆石, 等. 血液透析患者微炎症状态与骨骼肌消耗性营养不良的临床研究. 中国中西医结合肾病杂志, 2013, 14(7): 582-585.
|
16. |
王刚, 姜群, 张东亮, 等. 维持性血液透析患者骨质疏松患病情况及其危险因素分析. 临床和实验医学杂志, 2013, 12(16): 1277-1279.
|
17. |
王超超, 林永强, 赵润英. 维持性血液透析患者骨密度分析. 浙江医学, 2018, 40(5): 484-485.
|
18. |
王峥嵘, 朱昀. 老年慢性疾病患者骨质疏松的相关因素分析. 中华老年医学杂志, 2014, 33(3): 272-275.
|
19. |
李桂英, 肖太玲, 秦燕. 慢性肾衰竭与骨质疏松的相关因素分析. 中国骨质疏松杂志, 2011, 17(5): 405-407.
|
20. |
Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int, 2008, 19(4): 437-447.
|
21. |
Kanis JA, McCloskey EV, Johansson H, et al. Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK. Osteoporos Int, 2008, 19(10): 1395-1408.
|
22. |
Fujiwara S, Nakamura T, Orimo H, et al. Development and application of a Japanese model of the WHO fraclare risk assessment tool (FRAX). Osteoporos Int, 2008, 19(4): 429-435.
|
23. |
刘敏燕, 李春霖. 老年骨质疏松症的防治策略及进展. 中华老年多器官疾病杂志, 2013, 12(5): 397-400.
|
24. |
Chang AJ, Ying Q, Chen XN, et al. Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis. Osteoporos Int, 2016, 27(12): 3599-3606.
|
25. |
钱慕周, 尹友生, 何勇, 等. 雌激素受体调节剂对血液透析女患者骨质疏松的作用. 中华肾脏病杂志, 2012, 28(3): 239-240.
|
26. |
Miller PD. Bone disease in CKD: a focus on osteoporosis diagnosis and management. Am J Kidney Dis, 2014, 64(2): 290-304.
|
27. |
左薇, 费琦, 杨雍, 等. BMD、OSTA 与 FRAX®预测绝经后女性骨质疏松性骨折风险的比较研究. 中国骨质疏松杂志, 2015, 21(1): 48-52.
|
28. |
Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Ann Intern Med, 2018, 168(6): 422-430.
|